287 related articles for article (PubMed ID: 28586302)
1. Comparison of 25-hydroxyvitamin D and metabolic parameters between women with and without polycystic ovarian syndrome.
Ng BK; Lee CL; Lim PS; Othman H; Ismail NAM
Horm Mol Biol Clin Investig; 2017 Jun; 31(3):. PubMed ID: 28586302
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome.
Li HW; Brereton RE; Anderson RA; Wallace AM; Ho CK
Metabolism; 2011 Oct; 60(10):1475-81. PubMed ID: 21550088
[TBL] [Abstract][Full Text] [Related]
3. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
Wang L; Lv S; Li F; Yu X; Bai E; Yang X
Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
[No Abstract] [Full Text] [Related]
5. Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities.
Figurová J; Dravecká I; Javorský M; Petríková J; Lazúrová I
Wien Klin Wochenschr; 2016 Sep; 128(17-18):641-8. PubMed ID: 25787215
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D predictors in polycystic ovary syndrome: a meta-analysis.
Bacopoulou F; Kolias E; Efthymiou V; Antonopoulos CN; Charmandari E
Eur J Clin Invest; 2017 Oct; 47(10):746-755. PubMed ID: 28795765
[TBL] [Abstract][Full Text] [Related]
7. 25-Hydroxyvitamin D levels are related to hyperinsulinemia in polycystic ovary syndrome.
Güdücü N; Görmüş U; Kutay SS; Kavak ZN; Dünder I
Gynecol Endocrinol; 2014 Aug; 30(8):557-60. PubMed ID: 24819314
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of vitamin D deficiency in infertile women with polycystic ovarian syndrome and its association with metabolic syndrome - A prospective observational study.
Mogili KD; Karuppusami R; Thomas S; Chandy A; Kamath MS; Tk A
Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():15-19. PubMed ID: 30096464
[TBL] [Abstract][Full Text] [Related]
9. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
[TBL] [Abstract][Full Text] [Related]
10. Serum 25-Hydroxy Vitamin D Levels in Turkish Adolescent Girls with Polycystic Ovary Syndrome and the Correlation with Clinical/Biochemical Parameters.
Bostanci EI; Ozler S; Yilmaz NK; Yesilyurt H
J Pediatr Adolesc Gynecol; 2018 Jun; 31(3):270-273. PubMed ID: 28782659
[TBL] [Abstract][Full Text] [Related]
11. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D Deficiency among Adolescent Females with Polycystic Ovary Syndrome.
Sadhir M; Kansra AR; Menon S
J Pediatr Adolesc Gynecol; 2015 Oct; 28(5):378-81. PubMed ID: 26209866
[TBL] [Abstract][Full Text] [Related]
13. Associations of vitamin D concentration with metabolic and hormonal indices in women with polycystic ovary syndrome presenting abdominal and gynoidal type of obesity.
Kozakowski J; Kapuścińska R; Zgliczyński W
Ginekol Pol; 2014 Oct; 85(10):765-70. PubMed ID: 25546928
[TBL] [Abstract][Full Text] [Related]
14. Genotype-independent association between vitamin D deficiency and polycystic ovarian syndrome in Lahore, Pakistan.
Lone NM; Riaz S; Eusaph AZ; Mein CA; Wozniak EL; Xenakis T; Wu Z; Younis S; Jolliffe DA; Junaid K; Martineau AR
Sci Rep; 2020 Feb; 10(1):2290. PubMed ID: 32042037
[TBL] [Abstract][Full Text] [Related]
15. The effect of alfacalcidiol and metformin on metabolic disturbances in women with polycystic ovary syndrome.
Figurová J; Dravecká I; Petríková J; Javorský M; Lazúrová I
Horm Mol Biol Clin Investig; 2017 Mar; 29(3):85-91. PubMed ID: 28157691
[TBL] [Abstract][Full Text] [Related]
16. Low vitamin D3 and high anti-Müllerian hormone serum levels in the polycystic ovary syndrome (PCOS): Is there a link?
Cappy H; Giacobini P; Pigny P; Bruyneel A; Leroy-Billiard M; Dewailly D; Catteau-Jonard S
Ann Endocrinol (Paris); 2016 Oct; 77(5):593-599. PubMed ID: 26997468
[TBL] [Abstract][Full Text] [Related]
17. Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study.
Santos BR; Lecke SB; Spritzer PM
PLoS One; 2017; 12(3):e0173695. PubMed ID: 28278285
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between vitamin D deficiency and metabolic syndrome].
González-Molero I; Rojo G; Morcillo S; Pérez-Valero V; Rubio-Martín E; Gutierrez-Repiso C; Soriguer F
Med Clin (Barc); 2014 Jun; 142(11):473-7. PubMed ID: 24216018
[TBL] [Abstract][Full Text] [Related]
19. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome.
Feldman RA; O'Neill K; Butts SF; Dokras A
Fertil Steril; 2017 Jan; 107(1):276-281. PubMed ID: 27842995
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome.
Wehr E; Trummer O; Giuliani A; Gruber HJ; Pieber TR; Obermayer-Pietsch B
Eur J Endocrinol; 2011 May; 164(5):741-9. PubMed ID: 21389086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
